{
    "info": {
        "nct_id": "NCT06419634",
        "official_title": "Phase I Multicenter, Open-Label, First-in-Human Study of BMS-986497 (ORM-6151) in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
        "inclusion_criteria": "* Adults with primary or secondary relapsed and/or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).\n* Detectable levels of cluster of differentiation 33 (CD33) expression.\n* Failed alternative therapies with established benefit.\n* Eastern Cooperative Oncology Group (ECOG) performance status ≤2 and adequate organ function.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Acute Promyelocytic Leukemia.\n* Clinically active central nervous system leukemia.\n* Active malignant solid tumor.\n* Pregnant or breastfeeding.\n* Other protocol-defined inclusion/exclusion criteria apply.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Failed alternative therapies with established benefit.",
            "criterions": [
                {
                    "exact_snippets": "Failed alternative therapies with established benefit.",
                    "criterion": "alternative therapies with established benefit",
                    "requirements": [
                        {
                            "requirement_type": "treatment response",
                            "expected_value": "failed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Detectable levels of cluster of differentiation 33 (CD33) expression.",
            "criterions": [
                {
                    "exact_snippets": "Detectable levels of cluster of differentiation 33 (CD33) expression.",
                    "criterion": "CD33 expression",
                    "requirements": [
                        {
                            "requirement_type": "detectable level",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adults with primary or secondary relapsed and/or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).",
            "criterions": [
                {
                    "exact_snippets": "Adults",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "primary or secondary relapsed and/or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "disease type",
                            "expected_value": [
                                "acute myeloid leukemia (AML)",
                                "myelodysplastic syndrome (MDS)"
                            ]
                        },
                        {
                            "requirement_type": "disease status",
                            "expected_value": [
                                "primary relapsed",
                                "secondary relapsed",
                                "primary refractory",
                                "secondary refractory"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status ≤2 and adequate organ function.",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status ≤2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Other protocol-defined inclusion/exclusion criteria apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol-defined inclusion/exclusion criteria apply.",
                    "criterion": "other protocol-defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active malignant solid tumor.",
            "criterions": [
                {
                    "exact_snippets": "Active malignant solid tumor",
                    "criterion": "malignant solid tumor",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Acute Promyelocytic Leukemia.",
            "criterions": [
                {
                    "exact_snippets": "Acute Promyelocytic Leukemia",
                    "criterion": "Acute Promyelocytic Leukemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically active central nervous system leukemia.",
            "criterions": [
                {
                    "exact_snippets": "Clinically active central nervous system leukemia",
                    "criterion": "central nervous system leukemia",
                    "requirements": [
                        {
                            "requirement_type": "clinical activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}